Skip to main content
. Author manuscript; available in PMC: 2023 Aug 1.
Published in final edited form as: Transplant Cell Ther. 2022 May 9;28(8):473–482. doi: 10.1016/j.jtct.2022.05.004

Table 2.

Patient Reported Adverse Events using PRO-CTCAE grading.

N Any Grade (adjusted for baseline) Grade 3 (adjusted for baseline)
PRO-CTCAE term AUTO CART AUTO, n(%) CART, n(%) Fisher P AUTO, n(%) CART, n(%) Fisher P
Mouth or Throat Sores 33 34 11 (33%) 15 (44%) 0.46 3 (9%) 1 (3%) 0.36
Decreased Appetite 33 34 28 (85%) 22 (65%) 0.09 10 (30%) 5 (15%) 0.15
Diarrhea 33 34 25 (76%) 15 (44%) 0.01 7 (21%) 1 (3%) 0.03
Numbness/Tingling in Hands/Feet 33 34 16 (48%) 8 (24%) 0.04 6 (18%) 1 (3%) 0.054
Pain 33 34 18 (55%) 16 (47%) 0.63 11 (33%) 2 (6%) 0.006
Fatigue 32 33 22 (69%) 18 (55%) 0.31 14 (44%) 6 (18%) 0.03
Anxiety 33 33 11 (33%) 13 (39%) 0.80 2 (6%) 2 (6%) 1.00
Sad/Unhappy Feelings 33 33 11 (33%) 9 (27%) 0.79 2 (6%) 0 (0%) 0.49
N Any Grade (adjusted for baseline) Grade 3 (adjusted for baseline)
PRO-CTCAE term ALLO CART ALLO, n(%) CART, n(%) Fisher P ALLO, n(%) CART, n(%) Fisher P
Mouth or Throat Sores 34 34 27 (79%) 15 (44%) 0.006 17 (50%) 1 (3%) <0.001
Decreased Appetite 34 34 33 (97%) 22 (65%) 0.001 18 (53%) 5 (15%) 0.002
Diarrhea 33 34 28 (85%) 15 (44%) <0.001 8 (24%) 1 (3%) 0.01
Numbness/Tingling in Hands/Feet 33 34 17 (52%) 8 (24%) 0.02 1 (3%) 1 (3%) 1.00
Pain 34 34 31 (91%) 16 (47%) <0.001 23 (68%) 2 (6%) <0.001
Fatigue 33 33 30 (91%) 18 (55%) 0.002 20 (61%) 6 (18%) <0.001
Anxiety 34 33 16 (47%) 13 (39%) 0.62 5 (15%) 2 (6%) 0.43
Sad/Unhappy Feelings 34 33 19 (56%) 9 (27%) 0.03 6 (18%) 0 (0%) 0.03